Article info
PDFOriginal research
Management of high, moderate, and low penetrance ovarian cancer susceptibility mutations: an assessment of current risk reduction practices
- Correspondence to Dr Catherine H. Watson, Department of Obstetrics and Gynecology, Duke University Medical Center, Durham, NC 27710, USA; catherine.h.watson{at}duke.edu
Citation
Management of high, moderate, and low penetrance ovarian cancer susceptibility mutations: an assessment of current risk reduction practices
Publication history
- Received April 24, 2020
- Revision received July 30, 2020
- Accepted August 3, 2020
- First published August 23, 2020.
Online issue publication
October 06, 2020
Article Versions
- Previous version (23 August 2020).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© IGCS and ESGO 2020. No commercial re-use. See rights and permissions. Published by BMJ.